NOD2 rs34688636: Understanding the p.Arg702Trp Variant
The rs34688636 variant is a specific genetic change in the NOD2 gene, resulting in an amino acid substitution known as p.Arg702Trp. Research has associated this variant with an increased predisposition to developing Crohn disease, a type of inflammatory bowel disease.
What each genotype means
Typical NOD2 function
This genotype represents the most common form of the NOD2 gene, which is involved in the body's innate immune response to bacteria. Individuals with this profile do not carry the specific R702W variant associated with increased susceptibility to Crohn disease. Having this genotype does not eliminate the possibility of developing inflammatory bowel disease, as many other genetic and environmental factors contribute to risk.
This is the most common genotype, found in the vast majority of individuals across all global populations.
Increased Crohn disease susceptibility
This genotype indicates the presence of one copy of the R702W variant, which can impair the NOD2 protein's ability to recognize bacterial patterns in the gut. Research suggests that carriers of this variant have a statistically higher predisposition to developing Crohn disease compared to those without it. This is a complex risk factor, and many people with this genotype will never develop the condition.
This genotype is carried by approximately 2-3% of individuals of European ancestry and is considered rare in Asian and African populations.
Elevated Crohn disease risk
This genotype indicates the presence of two copies of the R702W variant, which may lead to a more significant reduction in the function of the NOD2 immune sensor. Studies indicate that individuals with two copies of risk-associated NOD2 variants face a substantially higher relative risk of developing Crohn disease than those with one or no copies. Because this is a complex genetic association, you should discuss your overall health history and any concerns with a gastroenterologist or genetic counselor.
This genotype is very rare, occurring in a small fraction of the population, primarily within European-descended groups.
What is the rs34688636 Variant?
The rs34688636 variant is a single nucleotide polymorphism (SNP) located within the NOD2 gene. In genetic terms, this variant represents a missense mutation, meaning the change in the DNA sequence leads to a different amino acid being incorporated into the resulting protein. Specifically, the substitution of arginine for tryptophan at position 702 (p.Arg702Trp) alters the structure of the NOD2 protein. This gene is situated on chromosome 16 and plays a critical role in the human immune system. Because this variant is located in a region of the gene responsible for recognizing bacterial components, researchers have focused on how this structural change might impact the body's ability to distinguish between harmful pathogens and beneficial gut bacteria. Understanding this SNP requires looking at how it sits within the broader context of the NOD2 protein's functional domains, which are essential for maintaining intestinal homeostasis and regulating inflammatory responses.
The Role of the NOD2 Gene
The NOD2 gene provides instructions for making a protein that acts as an intracellular pattern recognition receptor. This protein is primarily expressed in immune cells, such as macrophages and dendritic cells, as well as in specialized intestinal cells called Paneth cells. Its main function is to detect muramyl dipeptide, a component of bacterial cell walls. When the NOD2 protein detects this component, it triggers a signaling cascade that activates the NF-kappaB pathway, leading to the production of inflammatory cytokines and antimicrobial peptides. This process is vital for the body to mount an appropriate immune response against invading bacteria. When the NOD2 gene is functioning correctly, it helps maintain the integrity of the intestinal lining and prevents excessive inflammation. Disruptions in this gene, such as those caused by the p.Arg702Trp variant, can impair these protective mechanisms, potentially leading to an overactive or dysregulated immune response in the gastrointestinal tract.
Research Associations and Evidence Strength
Scientific research has consistently identified rs34688636 as a risk factor for Crohn disease, a chronic inflammatory condition of the digestive tract. The evidence for this association is considered well-established in the context of genetic epidemiology, particularly in populations of European descent. Studies have shown that individuals carrying this variant have a higher statistical likelihood of developing the condition compared to those who do not. However, it is important to note that the presence of this variant does not guarantee the development of disease. Many individuals with the variant remain healthy, suggesting that other genetic, environmental, and lifestyle factors are necessary for the disease to manifest. The evidence strength is categorized as limited in some clinical databases because the variant's penetrance is incomplete, meaning the clinical outcome is not strictly determined by the genotype alone. Researchers continue to study how this variant interacts with other genetic markers and environmental triggers to influence disease risk.
Population Frequency and Distribution
The frequency of the rs34688636 variant varies significantly across different global populations. According to large-scale genomic databases, the minor allele frequency is approximately 0.02 to 0.03 in individuals of European ancestry. This means that a small but notable percentage of the European population carries at least one copy of the variant. In contrast, the variant is considered rare or absent in many Asian and African populations. This distribution pattern is a common feature of many disease-associated variants, which often show ancestry-specific frequencies due to historical population migration and genetic drift. Because the variant is relatively uncommon even in European populations, it is not typically included in standard clinical screening panels for the general public. Researchers use these frequency data to better understand the evolutionary history of the NOD2 gene and to refine risk assessment models for inflammatory bowel diseases across diverse ethnic groups.
Interpreting Your Genetic Information
If you have information about your status for the rs34688636 variant, it is essential to interpret it within the context of your overall health. Genetic testing results for this SNP are not diagnostic, meaning they cannot predict with certainty whether you will develop Crohn disease. Because the risk associated with this variant is complex and influenced by many other factors, it should not be used to make medical decisions in isolation. If you are concerned about your risk for inflammatory bowel disease or have symptoms such as persistent abdominal pain, diarrhea, or weight loss, you should consult with a healthcare professional or a gastroenterologist. They can provide a comprehensive evaluation based on your personal and family medical history. Never use genetic data to self-diagnose or alter your lifestyle or medical treatments without professional guidance. Genetic counseling can be a valuable resource for understanding the implications of your results and discussing appropriate screening or monitoring strategies.
How common is this variant?
The minor allele frequency is approximately 0.02-0.03 in European ancestries, while the variant is rare in Asian and African populations.
Frequently asked questions
Does having the rs34688636 variant mean I will get Crohn disease?
No, having this variant does not mean you will develop Crohn disease. It is a risk factor, but many people with the variant never develop the condition, as it is influenced by many other genetic and environmental factors.
Should I get tested for the NOD2 rs34688636 variant?
Routine testing for this variant is not recommended for the general population. If you have symptoms of inflammatory bowel disease or a strong family history, consult a doctor to discuss appropriate diagnostic testing.
What is the difference between a SNP and a mutation?
A SNP is a common variation in a single DNA building block, while the term mutation often refers to a change that may have a more significant impact on health. In this context, rs34688636 is a SNP that results in a missense mutation in the NOD2 protein.
Can I change my risk if I have this variant?
While you cannot change your genetics, you can focus on overall gut health through a balanced diet and regular medical check-ups. Always discuss any health concerns or lifestyle changes with your healthcare provider.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs34688636?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in NOD2
Also known as Leu1007fsinsC (3020insC), this frameshift insertion/variant in NOD2 is one of the strongest genetic risk factors for Crohn's disease susceptibility.
Missense variant p.Gly908Arg in NOD2 associated with increased risk for inflammatory bowel disease.